ArticleKidney international reports2024

Effects of Once-Weekly Semaglutide on Kidney Disease Outcomes by KDIGO Risk Category in the SUSTAIN 6 Trial.

Katherine R Tuttle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.